Key facts
- This page summarizes Schuth Alexander O's Form 4 filing for Denali Therapeutics Inc. (DNLI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Aug 2026, 17:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
Additional SEC filing notes
Footnote F1
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
Footnote F2
Includes 135,475 Unvested RSUs.
Footnote F3
Includes 1,792 shares acquired under the ESPP Purchase on June 1, 2026.
Footnote F4
The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.